Newron Pharmaceuticals S.p.A. (“Newron”) [Ticker: SIX: NWRN], a research and development company focused on novel central nervous system (CNS) and pain therapies, today announced that Stefan Weber, CEO, will provide a company update at the 17th Annual BIO CEO & Investor Conference in New York City. The presentation is on Feb. 9, 2015, at 4 p.m. in the Conrad room at the Waldorf Astoria hotel.
Help employers find you! Check out all the jobs and post your resume.
